Proliferative activity and apoptosis in thymic epithelial neoplasms

Modern Pathology

Volumn 15, Issue 12, 2002, Pages 1326-1332

  Hiroshima, Kenzo ^a   Iyoda, Akira ^a   Toyozaki, Tetsuya ^a   Supriatna, Yana ^a   Shibuya, Kiyoshi ^a   Shimamura, Fumihiko ^a   Haga, Yukiko ^a   Yoshida, Shigetoshi ^a   Fujisawa, Takehiko ^a   Ohwada, Hidemi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bax; Bcl 2; Ki 67; P53; Survivin; Thymic carcinoma; Thymoma

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE MARKER; EPITHELIUM TUMOR; EVALUATION; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THYMOMA; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THYMOMA; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 18744368436     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000038463.67854.84     Document Type: Article

References (37)

1. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol 1978;9:495-515.
2. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 1985;407:119-49.
3. Kirchner T, Müller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. In: Fenoglio-Preiser CM, Wolff M, Rike F, editors. Progress in surgical pathology. Vol. 10. Philadelphia: Field and Wood; 1989. p. 167-89.
4. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999; 111:826-33.
5. Rosai J, Sobin LH. World Health Organization. Histological typing of tumours of the thymus. 2nd Ed. Berlin: Springer-Verlag; 1999.
6. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
7. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994;369:321-3.
8. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
9. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
10. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
11. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
12. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4.
13. Wyllie AH. The biology of cell death in tumours. Anticancer Res 1985;5:131-6.
14. Rahilly MA, Edwards CW, Crocker J, Murray P. Epithelial cell type, clinical behavior and AgNOR counts in thymic epithelial tumours. Anal Cell Pathol 1991;3:203-13.
15. Tateyama H, Mizuno T, Tada T, Eimoto T, Hashimoto T, Masaoka A. Thymic epithelial tumours: Evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizing regions. Virchows Arch A Pathol Anat Histopathol 1993;422:265-9.
16. Yang WI, Efird JT, Quintanilla-Martinez L, Choi N, Harris NL. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies. Hum Pathol 1996;27:70-6.
17. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
18. Migheli A, Attanasio A, Schiffer D. Ultrastructural detection of DNA strand breaks in apoptotic neural cells by in situ end-labelling techniques. J Pathol 1995;176:27-35.
19. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
20. Hiroshima K, Toyozaki T, Iyoda A, Yusa T, Fujisawa T, Ohwada H. Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum. Cancer 2001;92:1798-806.
21. Sinicrope FA, Roddey G, McDonnell TI, Shen Y, Cleary KR, Stephens LC. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 1996;2:1999-2006.
22. Kawasaki H, Toyoda M, Shinohara H, Okuda J, Watanabe I, Yamamoto T, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 2001;91:2026-32.
23. Isacson C, Kessis TD, Hedrick L, Cho KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996;56:669-74.
24. Berges RR, Vukanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, et al. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res 1995;1:473-80.
25. Tateyama H, Eimoto T, Tada T, Inagaki H, Hattori H, Takino H. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. Mod Pathol 1997;10:983-91.
26. Chen FF, Yan JJ, Jin YT, Su IJ. Detection of bcl-2 and p53 in thymoma: Expression of bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol 1996;27:1089-92.
27. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991;352:345-7.
28. Aizawa K, Ueki K, Suzuki S, Yabusaki H, Kanda T, Nishimaki T, et al. Apoptosis and Bcl-2 expression in gastric carcinomas: Correlation with clinicopathological variables, p53 expression, cell proliferation and prognosis. Int J Oncol 1999;14:85-91.
29. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
30. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. J Am Coll Surg 1997;185:398-403.
31. Ozer E, Canda T, Kuyucuodlu F. p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume. Cancer Lett 1998;122:101-6.
32. Raouf A, Evoy D, Carton E, Mulligan E, Griffin M, Sweeney E, et al. Spontaneous and inducible apoptosis in oesophageal adenocarcinoma. Br J Cancer 2001;85:1781-6.
33. Slootweg PJ, Koole R, Hordijk GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol 1994;30B:138-41.
34. Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, et al. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Cancer 1998;82:86-95.
35. Tateyama H, Eimoto T, Tada T, Mizuno T, Inagaki H, Hata A, et al. p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. Am J Clin Pathol 1995;104:375-81.
36. Lardinois D, Rechsteiner R, Lang RH, Gugger M, Betticher D, von Briel C, et al. Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000;69:1550-5.
37. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: A study of 146 consecutive tumors. Am J Surg Pathol 2001;25:103-10.